Jazz Pharmaceuticals’ (JAZZ) Buy Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) in a research report released on Wednesday,Benzinga reports. They currently have a $200.00 price target on the specialty pharmaceutical company’s stock. Other research analysts have also issued research reports about the company. Morgan Stanley reissued an “overweight” rating […]
Needham & Company LLC reaffirmed their buy rating on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) in a research report released on Wednesday,Benzinga reports. They currently have a $200.00 price target on the specialty pharmaceutical company’s stock. Other research analysts have also issued research reports about the company. Morgan Stanley reissued an “overweight” rating […]
